NGS-Based RNA-Sequencing Market Competitive Landscape Analysis and Key Companies Profile to 2027


Posted March 6, 2023 by panditsavni

NGS- Based RNA- Seq Market was valued at US$ 1,240.87 Mn in 2017 and is estimated to reach US$ 7,984.90 Mn by 2027. The market is estimated to grow with a CAGR of 19.3% from 2018- 2027

 
According to The Insight Partners market research study titled ‘NGS- Based RNA- Seq Market to 2027 - Global Analysis and Forecasts by Product & Services, Technology, Application and End User, the global NGS- based RNA- seq market was valued at US$ 1,240.87 Mn in 2017 and is estimated to reach US$ 7,984.90 Mn by 2027. The market is estimated to grow with a CAGR of 19.3% from 2018- 2027.The report highlights the trends prevalent in the global NGS- based RNA- seq market and the factors driving the market along with those that act as deterrents to its growth.

Global NGS- based RNA- seq market, based on the product & services is segmented into sample preparation, sequencing services, sequencing platform & consumables and data analysis, storage & management. The sample preparation segment is further bifurcated into method and workflow step segments. In 2017, sequencing platform & consumables segment held the largest share, by product& services. Additionally, the data analysis segment is anticipated to grow at a significant rate during the forecast period.

Global NGS- based RNA- seq market is expected to grow in the coming years, owing to the factors such as, reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, the risks related to genetic data and high cost of NGS instruments is act as a restraint for this market. On the other hand, barcode scanning for long reads sequences likely to add novel opportunities for NGS- based RNA- seq market, in the coming years.

The major players operating in the NGS- based RNA- seq market include Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen, F. Hoffmann- La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies, Perkinelmer, Inc. and Eurofins Scientific among others. The market players are focused towards bringing new and innovative product launches to sustain their position in the market. For instance, in October 2018, Agilent Technologies Inc. launched Agilent OnePGT, a genome- wide, next- generation sequencing (NGS) solution for preimplantation genetic testing (PGT).

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: [email protected]

Phone: +1-646-491-9876
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Savni
Country India
Categories Health
Tags ngsbased rnasequencing market , rnasequencing market
Last Updated March 6, 2023